• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.71% Nasdaq Up 1.77%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    4.38 Down 0.01(0.23%) 2:13PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.39
    Open:4.40
    Bid:4.36 x 300
    Ask:4.40 x 200
    1y Target Est:9.00
    Beta:1.26
    Next Earnings Date:N/A
    Day's Range:4.31 - 4.49
    52wk Range:2.97 - 7.10
    Volume:27,324
    Avg Vol (3m):80,334
    Market Cap:82.79M
    P/E (ttm):N/A
    EPS (ttm):-0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):306.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback